NKCx Histopathological outcome* within 12 months after cervix cytology in 2021 |
231 Jönköping |
Benign | LSIL | HSIL | AIS | Cancer | Other | PAD missing | Total | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cytologi | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel |
Benign sample | 489 | 4.1% | 129 | 1.1% | 17 | 0.1% | 2 | 0.0% | . | . | 2 | 0.0% | 11243 | 94.6% | 11882 | 100.0% |
ASCUS | 505 | 31.8% | 431 | 27.1% | 141 | 8.9% | 3 | 0.2% | . | . | 5 | 0.3% | 504 | 31.7% | 1589 | 100.0% |
LSIL | 137 | 21.6% | 278 | 43.8% | 100 | 15.8% | . | . | . | . | 1 | 0.2% | 118 | 18.6% | 634 | 100.0% |
Atypical glandular cells/AGC | 7 | 36.8% | 4 | 21.1% | . | . | 2 | 10.5% | 1 | 5.3% | 1 | 5.3% | 4 | 21.1% | 19 | 100.0% |
Unclear atypia | . | . | 2 | 40.0% | . | . | . | . | . | . | . | . | 3 | 60.0% | 5 | 100.0% |
ASC-H | 26 | 15.7% | 53 | 31.9% | 83 | 50.0% | 1 | 0.6% | 1 | 0.6% | . | . | 2 | 1.2% | 166 | 100.0% |
HSIL | 10 | 4.2% | 41 | 17.2% | 175 | 73.5% | 4 | 1.7% | 3 | 1.3% | 1 | 0.4% | 4 | 1.7% | 238 | 100.0% |
Suspected Adenocarcinom | . | . | . | . | . | . | 1 | 50.0% | . | . | . | . | 1 | 50.0% | 2 | 100.0% |
Adenocarcinoma | . | . | . | . | . | . | . | . | . | . | . | . | 1 | 100.0% | 1 | 100.0% |
Malignant tumor with unclear origin | . | . | 1 | 33.3% | . | . | . | . | . | . | 1 | 33.3% | 1 | 33.3% | 3 | 100.0% |
Squamous cell cancer | . | . | . | . | 2 | 33.3% | . | . | 3 | 50.0% | . | . | 1 | 16.7% | 6 | 100.0% |
Totalt | 1174 | 8.1% | 939 | 6.5% | 518 | 3.6% | 13 | 0.1% | 8 | 0.1% | 11 | 0.1% | 11882 | 81.7% | 14545 | 100.0% |
NOTE: Histopathological outcome from T83x taken into account. |
This list includes only one diagnosis (the highest ranking) per person, applies to both Cyt and Pad. |
* Harmonization of PAD codes classification between analysis registry and process registry has been carried out. PAD Class 0 (non diagnostic, unreasonable diagnosis) is excluded, and next PAD counts instead. |
The classes 2a, b, c and 3a (suspected premalignant, pre-malignant UNS, HPV, suspected malignant) are grouped into 'Other'. |
Process Registry's Class 1 (benign), 2d (LSIL) and 3b (manifest cancer) have all been introduced without exception. Some codes that occur beyond the scope of the process registry has been added to the different categories. |
Snomed codes in the category Cancer: |
---|
M80503, M80703, M81403 |